Antibiotics for the treatment of COVID-19
Emergencias. 2023 Oct;35(5):378-380.
doi: 10.55633/s3me/E028.2023.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Alemania.
- 2 Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Alemania.
- 3 Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Alemania.
- 4 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, General University Hospital Valencia, Valencia, España.
- 5 Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Alemania.
No abstract available
MeSH terms
-
Anti-Bacterial Agents* / therapeutic use
-
COVID-19*
-
Humans